LifePoint Health (LPNT) Given Consensus Rating of “Hold” by Brokerages

Shares of LifePoint Health (NASDAQ:LPNT) have been assigned a consensus recommendation of “Hold” from the twenty-two ratings firms that are covering the stock, MarketBeat.com reports. Two investment analysts have rated the stock with a sell recommendation, eleven have given a hold recommendation, six have assigned a buy recommendation and one has assigned a strong buy recommendation to the company. The average 12 month price target among brokerages that have issued a report on the stock in the last year is $53.77.

LPNT has been the subject of several recent analyst reports. BidaskClub upgraded LifePoint Health from a “hold” rating to a “buy” rating in a research note on Thursday, March 1st. Credit Suisse Group restated a “neutral” rating and issued a $48.00 target price (down from $54.00) on shares of LifePoint Health in a research note on Monday, February 26th. UBS upgraded LifePoint Health from a “market perform” rating to an “outperform” rating in a research note on Thursday, March 15th. Mizuho assumed coverage on LifePoint Health in a research note on Friday, March 23rd. They issued a “neutral” rating for the company. Finally, Cantor Fitzgerald restated a “hold” rating and issued a $50.00 target price on shares of LifePoint Health in a research note on Friday, February 23rd.

LifePoint Health stock traded down $0.10 during mid-day trading on Friday, hitting $53.25. 7,039 shares of the company were exchanged, compared to its average volume of 458,015. The company has a debt-to-equity ratio of 1.28, a current ratio of 1.76 and a quick ratio of 1.55. LifePoint Health has a 1-year low of $41.45 and a 1-year high of $67.95. The firm has a market capitalization of $2.08 billion, a P/E ratio of 14.72, a P/E/G ratio of 1.42 and a beta of 0.50.



LifePoint Health (NASDAQ:LPNT) last released its quarterly earnings data on Friday, May 4th. The company reported $1.22 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.13 by $0.09. LifePoint Health had a return on equity of 6.56% and a net margin of 0.48%. The firm had revenue of $1.60 billion during the quarter, compared to analyst estimates of $1.62 billion. During the same period in the prior year, the company posted $1.07 earnings per share. The business’s revenue for the quarter was down 1.7% compared to the same quarter last year. equities research analysts predict that LifePoint Health will post 4.3 EPS for the current fiscal year.

In other news, Chairman William F. Carpenter III purchased 21,368 shares of the firm’s stock in a transaction that occurred on Wednesday, February 28th. The shares were acquired at an average price of $46.80 per share, for a total transaction of $1,000,022.40. Following the completion of the acquisition, the chairman now directly owns 482,668 shares in the company, valued at $22,588,862.40. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. 8.80% of the stock is owned by company insiders.

A number of institutional investors have recently bought and sold shares of the stock. American Century Companies Inc. boosted its holdings in LifePoint Health by 4.0% in the first quarter. American Century Companies Inc. now owns 4,387,747 shares of the company’s stock valued at $206,224,000 after acquiring an additional 167,157 shares during the last quarter. BlackRock Inc. boosted its holdings in LifePoint Health by 0.8% in the first quarter. BlackRock Inc. now owns 3,443,790 shares of the company’s stock valued at $161,859,000 after acquiring an additional 27,579 shares during the last quarter. LSV Asset Management boosted its holdings in LifePoint Health by 6.6% in the first quarter. LSV Asset Management now owns 2,246,057 shares of the company’s stock valued at $105,564,000 after acquiring an additional 138,600 shares during the last quarter. Alliancebernstein L.P. boosted its holdings in LifePoint Health by 1.7% in the fourth quarter. Alliancebernstein L.P. now owns 1,762,076 shares of the company’s stock valued at $87,751,000 after acquiring an additional 28,721 shares during the last quarter. Finally, Letko Brosseau & Associates Inc. boosted its holdings in LifePoint Health by 4.6% in the first quarter. Letko Brosseau & Associates Inc. now owns 1,494,899 shares of the company’s stock valued at $70,260,000 after acquiring an additional 65,245 shares during the last quarter.

LifePoint Health Company Profile

LifePoint Health, Inc, through its subsidiaries, owns and operates community hospitals, regional health systems, physician practices, outpatient centers, and post-acute facilities in the United States. Its hospitals provide a range of medical and surgical services, such as general surgery, internal medicine, obstetrics, emergency room care, radiology, oncology, diagnostic care, coronary care, rehabilitation, and pediatric, as well as specialized services, including open-heart surgery, skilled nursing, psychiatric care, and neuro-surgery.

Analyst Recommendations for LifePoint Health (NASDAQ:LPNT)

Receive News & Ratings for LifePoint Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LifePoint Health and related companies with MarketBeat.com's FREE daily email newsletter.



Leave a Reply